The Archive · 7 posts
Explore breathable innovations! 🌬️ AOTI, Inc. (AOTI) on LSE is revolutionising multi-hyperbaric oxygen solutions for a healthier world. 💚
AOTI delivered 10% first-half revenue growth, while a proposed Medicare coverage decision offers a potentially significant growth catalyst.
July 27, 2026
Showing 6 of 7 posts
AOTI grew revenue 14% in 2025 but is cutting Arizona Medicaid services due to slow payments. A pivotal US Medicare decision remains the key catalyst for investors.
JoshuaMarch 30, 2026
AOTI delivered 14% FY25 revenue growth despite US headwinds, but an Arizona Medicaid crisis has trapped $15.6M in receivables, forcing a patient intake pause. All eyes are now on a pivotal CMS coverage decision.
JoshuaFebruary 23, 2026
AOTI posts 20.9% H1 revenue growth as Medicaid shines, with California, Germany, and UK validation wins boosting US reimbursement prospects.
JoshuaSeptember 22, 2025
AOTI cuts FY2025 guidance due to US healthcare disruption but secures key California Medicaid access, boosting long-term growth prospects despite short-term headwinds.
JoshuaJuly 21, 2025
AOTI's 2024 results: 32.9% revenue growth & 368.7% EBITDA surge, driven by Medicaid expansion, VA contract renewal & FDA-cleared wound care innovation.
JoshuaApril 28, 2025
AOTI's TWO2 therapy added to NHS Supply Chain Framework, cutting diabetic foot care costs by 16% and reducing amputations. Vital NHS savings.
JoshuaApril 22, 2025
September 22, 2025